| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2007 | 2006 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | 828,2 k € | -44.8% | 1,5 M € | -1.7% | 1,5 M € | +8.5% | 1,4 M € | +13.0% | 1,2 M € | -12.0% | 1,4 M € | +3.8% | 1,4 M € | +10.9% | 1,2 M € | -4.4% | 1,3 M € | +170.0% | 476,3 k € | +44.2% | 330,2 k € | |||||
| EBITDA | 151,3 k € | +629.9% | 20,7 k € | +144.7% | -46,4 k € | -39.3% | -33,3 k € | -120.0% | 166,6 k € | -37.9% | 268,4 k € | -4.3% | 280,5 k € | +205.1% | -267,0 k € | -233.1% | 200,6 k € | -51.9% | 416,7 k € | +5.8% | 394,0 k € | +4.1% | 378,5 k € | -11.2% | 426,3 k € | +920.2% | -52,0 k € | +86.8% | -393,1 k € | |
| Operating profit | 151,3 k € | +629.9% | 20,7 k € | +144.7% | -46,4 k € | -39.3% | -33,3 k € | -120.0% | 166,6 k € | -37.9% | 268,4 k € | -4.3% | 280,5 k € | +205.1% | -267,0 k € | -233.1% | 200,6 k € | -51.9% | 416,7 k € | +5.8% | 394,0 k € | +4.1% | 378,5 k € | -10.1% | 421,0 k € | +765.5% | -63,3 k € | +84.2% | -401,1 k € | |
| Profit/loss | 4,5 M € | -31.7% | 6,6 M € | +96.7% | 3,3 M € | +5821.2% | -58,4 k € | -100.3% | 22,1 M € | +10875.1% | 201,4 k € | -18.4% | 246,9 k € | +571.4% | -52,4 k € | -106.0% | 869,4 k € | +46.2% | 594,6 k € | +19.5% | 497,6 k € | -14.2% | 580,2 k € | -11.4% | 654,7 k € | +115.0% | -4,4 M € | -278.9% | -1,2 M € | |
| Equity | 5,6 M € | -9.9% | 6,2 M € | -54.6% | 13,6 M € | -2.2% | 13,9 M € | -0.4% | 14,0 M € | -9.1% | 15,4 M € | +1.3% | 15,2 M € | +1.7% | 14,9 M € | -0.3% | 15,0 M € | +6.2% | 14,1 M € | +4.4% | 13,5 M € | +3.8% | 13,0 M € | +4.7% | 12,4 M € | +83.5% | 6,8 M € | +436.6% | -2,0 M € | |
| Total assets | 27,5 M € | -0.0% | 27,5 M € | -19.5% | 34,2 M € | +0.0% | 34,1 M € | -0.2% | 34,2 M € | -2.5% | 35,1 M € | +1.1% | 34,7 M € | -0.1% | 34,7 M € | +105.6% | 16,9 M € | +5.0% | 16,1 M € | +6.1% | 15,2 M € | +8.4% | 14,0 M € | +7.1% | 13,0 M € | +36.6% | 9,6 M € | -28.6% | 13,4 M € | |
| Cash | 9,1 k € | -51.2% | 18,7 k € | -19.4% | 23,2 k € | +132.6% | 10,0 k € | -18.4% | 12,2 k € | -98.0% | 605,2 k € | +444.3% | 111,2 k € | +109.2% | 53,1 k € | +146.0% | 21,6 k € | -62.9% | 58,3 k € | +5.6% | 55,2 k € | +73.5% | 31,8 k € | -11.7% | 36,0 k € | -36.0% | 56,3 k € | +468.7% | 9,9 k € | |
| Debts | 21,9 M € | +2.8% | 21,3 M € | +3.8% | 20,5 M € | +1.5% | 20,2 M € | +0.0% | 20,2 M € | +2.8% | 19,7 M € | +0.9% | 19,5 M € | -1.3% | 19,8 M € | +952.7% | 1,9 M € | -4.2% | 2,0 M € | +19.5% | 1,6 M € | +70.1% | 964,1 k € | +54.5% | 624,1 k € | -60.5% | 1,6 M € | -89.2% | 14,7 M € | |
| Staff | — | — | — | 0 | 4 | 4,9 | 5 | 5 | 5 | 5 | 5 | 4,9 | 4,8 | 3,5 | 2,9 | |||||||||||||||
Private limited company · Oostende · incorporated on 09/09/2004
Private limited company profitable and well capitalised. Cash position declining (-51.2%).
Solid counterparty for a standard engagement.
METAGENICS EUROPE is a Private limited company incorporated in 2004. Its registered office is in Oostende.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette